科技人文

冷门学科的坚持与坚守——2023年诺贝尔生理学或医学奖的启示

  • 李泉秀 ,
  • 宋潇达 ,
  • 甄橙
展开
  • 1. 北京大学医学人文学院, 北京 100191;
    2. 中国药科大学生命科学与技术学院生化系, 南京 210038;
    3. 北京大学医史学研究中心, 北京 100191
李泉秀,博士研究生,研究方向为医学史,电子信箱:liqx11@126.com;甄橙(通信作者),教授,研究方向为中西医学比较史、医学专门史、女性与医学的历史、医学博物馆文化,电子信箱:zhencheng@bjmu.edu.cn

收稿日期: 2023-10-25

  修回日期: 2024-04-08

  网络出版日期: 2024-10-17

基金资助

国家社会科学基金冷门绝学研究专项学术团队项目(22VJXT010)

Perseverance and dedication of unpopular subjects: Insights from the 2023 Nobel Prize in Physiology or Medicine

  • LI Quanxiu ,
  • SONG Xiaoda ,
  • ZHEN Cheng
Expand
  • 1. School of Health Humanities, Peking University, Beijing 100191, China;
    2. Department of Biochemistry, School of Life Science and Technology, China Pharmaceutical University, Nanjing 210038, China;
    3. Center for History of Medicine, Peking University, Beijing 100191, China

Received date: 2023-10-25

  Revised date: 2024-04-08

  Online published: 2024-10-17

摘要

2023年诺贝尔生理学或医学奖表彰Katalin Karikó与Drew Weissman关于核苷碱基修饰的发现,该发现对于新冠mRNA疫苗研发至关重要。然而除此之外,新冠mRNA疫苗背后还有其他诸多重要的科研硕果值得关注。梳理了mRNA疫苗诞生过程中不可或缺的关键突破,如mRNA的发现、RNA的人工合成、RNA的碱基修饰、脂质体的创生和发展以及用于RNA递送的脂质纳米颗粒主要成分的确定等。新冠mRNA疫苗背后的重大科研突破凸显了坚守冷门而重要研究的难能可贵。指出了应正确认识热门学科与冷门学科的辩证关系,推动对冷门学科的倾斜支持,并关注学科发展的均衡配置。

本文引用格式

李泉秀 , 宋潇达 , 甄橙 . 冷门学科的坚持与坚守——2023年诺贝尔生理学或医学奖的启示[J]. 科技导报, 2024 , 42(18) : 124 -132 . DOI: 10.3981/j.issn.1000-7857.2023.10.01597

Abstract

The Nobel Prize in Physiology or Medicine 2023 was awarded to Katalin Karikó and Drew Weissman for their discovery of nucleoside base modifications, which was crucial for the development of COVID-19 mRNA vaccines. In addition, there are many other significant scientific achievements behind the novel coronavirus mRNA vaccine that deserve attention . This article reviewed the crucial breakthroughs of the mRNA vaccine, such as the initial discovery of mRNA, in vitro RNA synthesis, RNA base modifications, the creation and development of liposomes, and the determination of the major components of lipid nanoparticles for RNA delivery. The seminal scientific advancement which enabled COVID-19 mRNA vaccine underscored the inherent value of pursuing unpopular but important research. We should correctly understand the dialectical relationship between popular and unpopular fields of study, and rally preferential support for unpopular subjects, while ensuring a balanced allocation of resources across the spectrum of subject areas.

参考文献

[1] 甄橙. 程之范医学史[M]. 北京: 北京大学医学出版社, 2023: 64-65.
[2] Jenner E. An inquiry into the causes and effects of the variolae vaccinae[M]. London: Sampson Low, 1798.
[3] Press release for the Nobel Prize in Physiology or Medicine 2023[EB/OL]. [2023-10-16]. https://www.nobelprize.org/prizes/medicine/2023/press-release.
[4] Dolgin E. The tangled history of mRNA vaccines[J]. Nature, 2021, 597(7876): 318-324.
[5] Brenner S, Jacob F, Meselson M. An unstable intermediate carrying information from genes to ribosomes for protein synthesis[J]. Nature, 1961, 190(4776): 576-581.
[6] Gros F, Hiatt H, Gilbert W, et al. Unstable ribonucleic acid revealed by pulse labelling of Escherichia coli[J]. Nature, 1961, 190(4776): 581-585.
[7] Cobb M. Who discovered messenger RNA?[J]. Current Biology, 2015, 25(13): R526-R532.
[8] Jacob F, Monod J. Genetic regulatory mechanisms in the synthesis of proteins[J]. Journal of Molecular Biology, 1961, 3(3): 318-356.
[9] Butler E T, Chamberlin M J. Bacteriophage SP6-specific RNA polymerase. I. Isolation and characterization of the enzyme[J]. Journal of Biological Chemistry, 1982, 257(10): 5772-5778.
[10] Green M R, Maniatis T, Melton D A. Human β-globin pre-mRNA synthesized in vitro is accurately spliced in Xenopus oocyte nuclei[J]. Cell, 1983, 32(3): 681-694.
[11] Krieg P A, Melton D A. Formation of the 3' end of histone mRNA by post-transcriptional processing[J]. Nature, 1984, 308(5955): 203-206.
[12] Krieg P A, Melton D A. Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs [J]. Nucleic Acids Research, 1984, 12(18): 7057-7070.
[13] Krieg P A, Melton D A. In vitro RNA synthesis with SP6 RNA polymerase[J]. Methods in Enzymology, 1987, 155: 397-415.
[14] Lockard R E, Lingrel J B. The synthesis of mouse hemoglobin beta-chains in a rabbit reticulocyte cell-free system programmed with mouse reticulocyte 9S RNA[J]. Biochemical and Biophysical Research Communications, 1969, 37(2): 204-212.
[15] Lingrel J B. How I became a biochemist[J]. IUBMB Life, 2007, 59(10): 685-687.
[16] Gurdon J B, Lane C D, Woodland H R, et al. Use of frog eggs and oocytes for the study of messenger RNA and its translation in living cells[J]. Nature, 1971, 233(5316): 177-182.
[17] Wolff J A, Malone R W, Williams P, et al. Direct gene transfer into mouse muscle in vivo[J]. Science, 1990, 247(4949): 1465-1468.
[18] Jirikowski G F, Sanna P P, Maciejewski-Lenoir D, et al. Reversal of diabetes insipidus in Brattleboro rats: Intrahypothalamic injection of vasopressin mRNA[J]. Science, 1992, 255(5047): 996-998.
[19] Isaacs A, Cox R A, Rotem Z. Foreign nucleic acids as the stimulus to make interferon[J]. Lancet, 1963, 2(7299): 113-116.
[20] Karikó K, Buckstein M, Ni H P, et al. Suppression of RNA recognition by Toll-like receptors: The impact of nucleoside modification and the evolutionary origin of RNA[J]. Immunity, 2005, 23(2): 165-175.
[21] Karikó K, Muramatsu H, Welsh F A, et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability[J]. Molecular Therapy, 2008, 16(11): 1833-1840.
[22] Anderson B R, Muramatsu H, Nallagatla S R, et al. Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation[J]. Nucleic Acids Research, 2010, 38(17): 5884-5892.
[23] Deamer D W. From "Banghasomes" to liposomes: A memoir of Alec Bangham, 1921-2010[J]. FASEB Journal, 2010, 24(5): 1308-1310.
[24] Bangham A. The physical chemistry of self/non-self: Jigsaws, transplants and fetuses[J]. FASEB Journal, 2009, 23(11): 3644-3646.
[25] Bangham A D, Horne R W. Action of saponin on biological cell membranes[J]. Nature, 1962, 196(4858): 952-953.
[26] Glauert A M, Dingle J, Lucy J. Action of saponin on biological cell membranes[J]. Nature, 1962, 196(4858): 953-955.
[27] Bangham A D, Horne R W. Negative staining of phospholipids and their structural modification by surfaceactive agents as observed in the electron microscope[J]. Journal of Molecular Biology, 1964, 8(5): 660-668.
[28] Sessa G, Weissmann G. Phospholipid spherules (liposomes) as a model for biological membranes[J]. Journal of Lipid Research, 1968, 9(3): 310-318.
[29] Bangham A D, Standish M M, Watkins J C. Diffusion of univalent ions across the lamellae of swollen phospholipids[J]. Journal of Molecular Biology, 1965, 13(1): 238-252.
[30] Bangham A D, Standish M M, Weissmann G. The action of steroids and streptolysin S on the permeability of phospholipid structures to cations[J]. Journal of Molecular Biology, 1965, 13(1): 253-259.
[31] Dimitriadis G J. Translation of rabbit globin mRNA introduced by liposomes into mouse lymphocytes[J]. Nature, 1978, 274(5674): 923-924.
[32] Ostro M J, Giacomoni D, Lavelle D, et al. Evidence for translation of rabbit globin mRNA after liposome-mediated insertion into a human cell line[J]. Nature, 1978, 274(5674): 921-923.
[33] Felgner P L, Gadek T R, Holm M, et al. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure[J]. Proceedings of the National Academy of Sciences of the United States of America, 1987, 84(21): 7413-7417.
[34] Malone R W, Felgner P L, Verma I M. Cationic liposome-mediated RNA transfection[J]. Proceedings of the National Academy of Sciences of the United States of America, 1989, 86(16): 6077-6081.
[35] Malone R W. mRNA transfection of cultured eukaryotic cells and embryos using cationic liposomes[J]. Focus, 1989, 11(1): 61-66.
[36] Tang D C, DeVit M, Johnston S A. Genetic immunization is a simple method for eliciting an immune response [J]. Nature, 1992, 356(6365): 152-154.
[37] Martinon F, Krishnan S, Lenzen G, et al. Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA[J]. European Journal of Immunology, 1993, 23(7): 1719-1722.
[38] Conry R M, LoBuglio A F, Wright M, et al. Characterization of a messenger RNA polynucleotide vaccine vector [J]. Cancer Research, 1995, 55(7): 1397-1400.
[39] Horejs C. From lipids to lipid nanoparticles to mRNA vaccines[J]. Nature Reviews Materials, 2021, 6(12): 1075-1076.
[40] Cullis P R, de Kruijff B. Lipid polymorphism and the functional roles of lipids in biological membranes[J]. Biochimica et Biophysica Acta, 1979, 559(4): 399-420.
[41] Hafez I M, Ansell S, Cullis P R. Tunable pH-sensitive liposomes composed of mixtures of cationic and anionic lipids[J]. Biophysical Journal, 2000, 79(3): 1438-1446.
[42] Semple S C, Klimuk S K, Harasym T O, et al. Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: Formation of novel small multilamellar vesicle structures[J]. Biochimica et Biophysica Acta, 2001, 1510(1/2): 152-166.
[43] Fenske D B, Palmer L R, Chen T, et al. Cationic poly (ethyleneglycol) lipids incorporated into pre-formed vesicles enhance binding and uptake to BHK cells[J]. Biochimica et Biophysica Acta, 2001, 1512(2): 259-272.
[44] Maurer N, Wong K F, Stark H, et al. Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes[J]. Biophysical Journal, 2001, 80(5): 2310-2326.
[45] Hafez I M, Maurer N, Cullis P R. On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids[J]. Gene Therapy, 2001, 8(15): 1188-1196.
[46] Geall A J, Verma A, Otten G R, et al. Nonviral delivery of self-amplifying RNA vaccines[J]. Proceedings of the National Academy of Sciences of the United States of America, 2012, 109(36): 14604-14609.
[47] Alberer M, Gnad-Vogt U, Hong H S, et al. Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: An open-label, non-randomised, prospective, first-in-human phase 1 clinical trial[J]. Lancet, 2017, 390(10101): 1511-1520.
[48] Feldman R A, Fuhr R, Smolenov I, et al. mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials [J]. Vaccine, 2019, 37(25): 3326-3334.
[49] Polack F P, Thomas S J, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine[J]. The New England Journal of Medicine, 2020, 383(27): 2603-2615.
[50] Baden L R, El Sahly H M, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine[J]. The New England Journal of Medicine, 2021, 384(5): 403-416.
[51] Nobel Prize winner Katalin Karikó was 'demoted 4 times' at her old job. How she persisted: 'You have to focus on what's next'[EB/OL]. [2023-10-16]. https://www.cnbc.com/2023/10/06/nobel-prize-winner-katalin-karik-onbeing-demoted-perseverance-.html.
文章导航

/